Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
Australia
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Amidotricoic Acid
2. Amidotrizoate, Meglumine
3. Angiografin
4. Diatrizoate Methylglucamine
5. Diatrizoate, Meglumine
6. Diatrizoate, Methylglucamine
7. Diatrizoic Acid Methylglucamine
8. Gastrograffin
9. Gastrografin
10. Gastrographin
11. Ioxeol
12. Meglumine Amidotrizoate
13. Meglumine Diatrizoate
14. Meglumine, Diatrizoate
15. Methylglucamine Diatrizoate
16. Methylglucamine, Diatrizoate
17. Methylglucamine, Diatrizoic Acid
18. Reno 60
19. Reno M Dip
20. Reno M-dip
21. Reno Mdip
22. Renograffin
23. Renografin
24. Renografin M 76
25. Renografin M-76
26. Renografin M76
27. Sinografin
28. Triombrast
29. Triombrin
30. Urografin
31. Urografin 76
32. Urovist
33. Verografin
1. Meglumine Diatrizoate
2. 131-49-7
3. Meglumine Amidotrizoate
4. Renografin
5. Cardiografin
6. Cystografin
7. Renovist
8. Renocal
9. Angiovist 282
10. Diatrizoate Methylglucamine
11. Reno
12. Urovist Cysto
13. Urovist Cysto Pediatric
14. Urovist Meglumine Diu/ct
15. Meglumine Amidotrizoate Injection
16. Diatrizoate Meglumine [usp]
17. 131-49-7 (meglumine)
18. Diatrizoic Acid Meglumine Salt
19. 3x9mr4n98u
20. Angiografin
21. Urovist
22. 1-deoxy-1-(methylamino)-d-glucitol 3,5-diacetamido-2,4,6-triiodobenzoate (salt)
23. Renurix
24. Unipaque
25. Hypaque Meglumine
26. (2r,3r,4r,5s)-6-(methylamino)hexane-1,2,3,4,5-pentaol 3,5-diacetamido-2,4,6-triiodobenzoate
27. Cystographin Dilute
28. Diatrizoate Meglumine (usp)
29. Reno-m
30. Reno-m-dip
31. Benzoic Acid, 3,5-bis(acetylamino)-2,4,6-triiodo-, Compd. With 1-deoxy-1-(methylamino)-d-glucitol (1:1)
32. Hypaque 60
33. Renograffin M-76
34. Hypaque M 30
35. Hypaque 13.4
36. Reno-30
37. Hypaque-cysto
38. Reno-dip
39. Cystografin Dilute
40. Reno M 60
41. Gastrografin Oral (veterinary)
42. Reno-60
43. Md 60
44. Einecs 205-024-7
45. Unii-3x9mr4n98u
46. Hypaque (tn)
47. Urovist (tn)
48. Reno (tn)
49. 3,5-bis(acetamido)-2,4,6-triiodbenzoesaeure, 1-desoxy-1-methylamino-d-glucit-salz
50. Benzoic Acid, 3,5-diacetamido-2,4,6-triiodo-, Compd. With 1-deoxy-1-(methylamino)-d-glucitol
51. Schembl107036
52. Chembl1200839
53. Dtxsid20897171
54. Hms2234f23
55. Diatrizoate Meglumine [vandf]
56. Meglumine Amidotrizoate [mart.]
57. Glucitol, 1-deoxy-1-(methylamino)-, 3,5-diacetamido-2,4,6-triiodobenzoate (salt), D-
58. Meglumine Amidotrizoate [who-dd]
59. Diatrizoate Meglumine [green Book]
60. Diatrizoate Meglumine [orange Book]
61. Diatrizoic Acid Meglumine Salt [mi]
62. Diatrizoate Meglumine [usp Monograph]
63. Renocal Component Diatrizoate Meglumine
64. Angiovist Component Diatrizoate Meglumine
65. D02015
66. Meglumine Amidotrizoate Injection [jan]
67. Renovist Component Diatrizoate Meglumine
68. Diatrizoate Meglumine Component Of Renocal
69. Gastrovist Component Diatrizoate Meglumine
70. Renografin Component Diatrizoate Meglumine
71. Sinografin Component Diatrizoate Meglumine
72. Diatrizoate Meglumine Component Of Angiovist
73. Diatrizoate Meglumine Component Of Renovist
74. Gastrografin Component Diatrizoate Meglumine
75. Diatrizoate Meglumine Component Of Gastrovist
76. Diatrizoate Meglumine Component Of Renografin
77. Diatrizoate Meglumine Component Of Sinografin
78. Md-gastroview Component Diatrizoate Meglumine
79. Diatrizoate Meglumine Component Of Gastrografin
80. Q27114690
81. Diatrizoate Meglumine Component Of Md-gastroview
Molecular Weight | 809.1 g/mol |
---|---|
Molecular Formula | C18H26I3N3O9 |
Hydrogen Bond Donor Count | 9 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 9 |
Exact Mass | 808.8803 g/mol |
Monoisotopic Mass | 808.8803 g/mol |
Topological Polar Surface Area | 209 Ų |
Heavy Atom Count | 33 |
Formal Charge | 0 |
Complexity | 525 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 6 | |
---|---|
Drug Name | Cystografin |
Drug Label | Cystografin is a radiopaque contrast agent supplied as a sterile, clear, colorless to pale yellow, mobile or slightly viscous solution. Each mL provides 300 mg diatrizoate meglumine with 0.4 mg edetate disodium as a sequestering agent. Each mL of sol... |
Active Ingredient | Diatrizoate meglumine |
Dosage Form | Solution |
Route | Urethral |
Strength | 30% |
Market Status | Prescription |
Company | Bracco |
2 of 6 | |
---|---|
Drug Name | Cystografin dilute |
Drug Label | Cystografin Dilute (Diatrizoate Meglumine Injection USP 18%) is a radiopaque contrast agent supplied as a sterile, aqueous solution. Each mL provides 180 mg diatrizoate meglumine with 0.4 mg edetate disodium as a sequestering agent. Each mL of soluti... |
Active Ingredient | Diatrizoate meglumine |
Dosage Form | Solution |
Route | Urethral |
Strength | 18% |
Market Status | Prescription |
Company | Bracco |
3 of 6 | |
---|---|
Drug Name | Sinografin |
Drug Label | Sinografin (Diatrizoate Meglumine and lodipamide Meglumine Injection) is a sterile, nonpyrogenic, essentially colorless to pale yellow, aqueous radiopaque contrast medium for intrauterine instillation. Each mL provides 527 mg diatrizoate meglumine an... |
Active Ingredient | Diatrizoate meglumine; iodipamide meglumine |
Dosage Form | Solution |
Route | Intrauterine |
Strength | 26.8%; 52.7% |
Market Status | Prescription |
Company | Bracco |
4 of 6 | |
---|---|
Drug Name | Cystografin |
Drug Label | Cystografin is a radiopaque contrast agent supplied as a sterile, clear, colorless to pale yellow, mobile or slightly viscous solution. Each mL provides 300 mg diatrizoate meglumine with 0.4 mg edetate disodium as a sequestering agent. Each mL of sol... |
Active Ingredient | Diatrizoate meglumine |
Dosage Form | Solution |
Route | Urethral |
Strength | 30% |
Market Status | Prescription |
Company | Bracco |
5 of 6 | |
---|---|
Drug Name | Cystografin dilute |
Drug Label | Cystografin Dilute (Diatrizoate Meglumine Injection USP 18%) is a radiopaque contrast agent supplied as a sterile, aqueous solution. Each mL provides 180 mg diatrizoate meglumine with 0.4 mg edetate disodium as a sequestering agent. Each mL of soluti... |
Active Ingredient | Diatrizoate meglumine |
Dosage Form | Solution |
Route | Urethral |
Strength | 18% |
Market Status | Prescription |
Company | Bracco |
6 of 6 | |
---|---|
Drug Name | Sinografin |
Drug Label | Sinografin (Diatrizoate Meglumine and lodipamide Meglumine Injection) is a sterile, nonpyrogenic, essentially colorless to pale yellow, aqueous radiopaque contrast medium for intrauterine instillation. Each mL provides 527 mg diatrizoate meglumine an... |
Active Ingredient | Diatrizoate meglumine; iodipamide meglumine |
Dosage Form | Solution |
Route | Intrauterine |
Strength | 26.8%; 52.7% |
Market Status | Prescription |
Company | Bracco |
Contrast Media
Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-08-05
Pay. Date : 2015-04-08
DMF Number : 28740
Submission : 2014-10-31
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2020-04-24
Pay. Date : 2020-01-09
DMF Number : 34403
Submission : 2020-04-09
Status : Active
Type : II
NDC Package Code : 69037-0053
Start Marketing Date : 1982-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-04-25
Pay. Date : 2013-05-21
DMF Number : 27165
Submission : 2013-05-22
Status : Active
Type : II
NDC Package Code : 65392-1314
Start Marketing Date : 1969-08-21
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (35kg/35kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32737
Submission : 2018-07-25
Status : Active
Type : II
Date of Issue : 2022-06-15
Valid Till : 2025-07-14
Written Confirmation Number : WC-0183nA2
Address of the Firm :
NDC Package Code : 66577-031
Start Marketing Date : 2018-12-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4686
Submission : 1982-10-15
Status : Inactive
Type : II
Date of Issue : 2022-06-08
Valid Till : 2025-07-14
Written Confirmation Number : WC-0183A3-4
Address of the Firm :
NDC Package Code : 66577-031
Start Marketing Date : 2018-12-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 76055-0015
Start Marketing Date : 2019-12-31
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
About the Company : Biophore, founded in 2007, has established itself as a reliable partner in the development and manufacturing of niche and complex pharmaceutical products. With 4 USFDA and EU-appro...
About the Company : HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It...
About the Company : Curia is a global contract research, development and manufacturing organization (CDMO), offering products and services across the drug development spectrum to help our partners tur...
About the Company : Hetero is a research based global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & F...
About the Company : Sionc pharmaceuticals is specialized in manufacturing of complex and niche Active Pharmaceutical Ingredients in various therapeutic categories. Sionc has evolved as a reliable cont...
About the Company : VASUDHA PHARMA CHEM LIMITED was incorporated, as a public limited company under the Companies Act, 1956 in 1994-95 at Hyderabad in the state of Telangana, India. The company is eng...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info :
Registration Country : Sweden
Several substances refer to content
Brand Name : Gastrografin
Dosage Form : ORAL SOLUTION / REKTALLÖSNING
Dosage Strength : 370 MG / ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Italy
Brand Name : Gastrografin
Dosage Form : Diatrizoico Acid 370Mg Iodine/Ml 100Ml Oral Or Rectal Administration
Dosage Strength : soluz os rett 100 ml 370 mg iodine/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Norway
Brand Name : Gastrografin
Dosage Form : Melange/rectal fluid, resolution
Dosage Strength :
Packaging : Bottle
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Switzerland
Meglumini amidotrizoas; Natrii amidotrizoas
Brand Name : Gastrografin
Dosage Form : Solution
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Meglumini amidotrizoas; Natrii amidotrizoas
Brand Name : Gastrografin
Dosage Form : Solution
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Sweden
Several substances refer to content
Brand Name : Gastrografin
Dosage Form : ORAL SOLUTION / REKTALLÖSNING
Dosage Strength : 370 MG / ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Several substances refer to content
Brand Name : Gastrografin
Dosage Form : ORAL SOLUTION / REKTALLÖSNING
Dosage Strength : 370 MG / ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Global Sales Information
Dosage Form : Diatrizoico Acid 370Mg Iodine/Ml...
Dosage Strength : soluz os rett 100 ml 370 mg iodine/ml
Price Per Pack (Euro) : 12.53
Published in :
Country : Italy
RX/OTC/DISCN : Class H
Dosage Form : Melange/rectal fluid, resolution
Dosage Strength :
Price Per Pack (Euro) : 90.64
Published in :
Country : Norway
RX/OTC/DISCN :
Diatrizoate Meglumine; Diatrizoate Sodium
Dosage Form : Solution
Dosage Strength :
Price Per Pack (Euro) : 17.13
Published in :
Country : Switzerland
RX/OTC/DISCN : Class B
Diatrizoate Meglumine; Diatrizoate Sodium
Dosage Form : Solution
Dosage Strength :
Price Per Pack (Euro) : 171.3
Published in :
Country : Switzerland
RX/OTC/DISCN : Class B
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?